Coronavirus immunotherapy could arrive by early summer. Is ‘record time’ fast enough?

when to stop treatment

Blood-plasma-based cures aren’t just the stuff of movies. There’s plenty of science to back the idea that blood products from survivors of viral diseases — containing antibodies primed against the virus — can jump-start an immune response in new patients.

In confronting the Covid-19 pandemic, drug makers instead are racing to produce high-tech derivatives in the form of monoclonal or polyclonal antibodies engineered to home in on pieces of the coronavirus. Scientists view them as likely to be both safer and more targeted, but they have yet to provide a Hollywood ending to any outbreak.

It takes time to engineer and purify these antibodies — and past epidemics have often waned before the drugs were ready. They also present myriad logistical hurdles: They have to be kept cold, for instance, and must be infused into patients rather than swallowed. And they’re expensive.

Related article:  CRISPR-based 'PAC-MAN approach' could be answer to COVID-19 and other viral menaces

Now two companies say they hope to have treatments for Covid-19 ready in record time.

Japan-based Takeda Pharmaceutical says its unit devoted to plasma-derived therapies could have a product ready for quick approval to fight the coronavirus. New York-based biotech Regeneron has said it can be ready to test hundreds of potential antibodies in Covid-19 patients by early summer.

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
can you boost your immune system to prevent coronavirus spread x

Video: How to boost your immune system to guard against COVID and other illnesses

Scientists have recently developed ways to measure your immune age. Fortunately, it turns out your immune age can go down ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
gmo corn field x

Do GMO Bt (insect-resistant) crops pose a threat to human health or the environment?

Bt is a bacterium found organically in the soil. It is extremely effective in repelling or killing target insects but ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend